Atea Pharmaceuticals Inc. (AVIR) NASDAQ
$4.07 0.07 (1.62%)
Market Cap: $336.66M
As of 03/28/24 01:54 PM EDT. Market open.
Atea Pharmaceuticals Inc. (AVIR)
NASDAQ
$4.07
0.07 (1.62%)
Market Cap: $336.66M
As of 03/28/24 01:54 PM EDT. Market open.
atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the ... read more
atea pharmaceuticals, inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for severe viral diseases. the company's lead product candidate is at-527, a novel antiviral agent for the treatment of patients infected with severe acute respiratory syndrome coronavirus 2 and is under phase 3 clinical trial. it also develops at-787 which is under phase 2 clinical for the treatment of hepatitis c virus; at-752 which is under phase 2 clinical trial for the treatment of dengue; and at-889, at-934, and other product candidates for the treatment of respiratory syncytial virus are under phase 2 clinical trials. the company was incorporated in 2012 and is based in boston, massachusetts. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Corcoran Andrea | See Remarks | Feb 01, 2024 | Sale | $3.84 | 15,843 | 60,915 | 670,208 | Feb 02, 2024, 09:31 PM |
Sommadossi Jean-Pierre | President, CEO, and Chairman | Feb 01, 2024 | Sale | $3.85 | 56,910 | 218,819 | 116,557 | Feb 02, 2024, 09:30 PM |
Horga Maria Arantxa | Chief Medical Officer | Feb 01, 2024 | Sale | $3.84 | 15,870 | 60,963 | 25,664 | Feb 02, 2024, 09:29 PM |
Foster Wayne | EVP, Chief Accounting Officer | Feb 01, 2024 | Sale | $3.84 | 12,477 | 47,904 | 20,857 | Feb 02, 2024, 09:26 PM |
Vavricka John | Chief Commercial Officer | Feb 01, 2024 | Sale | $3.84 | 11,819 | 45,420 | 21,515 | Feb 02, 2024, 09:25 PM |
Hammond Janet MJ | Chief Development Officer | Feb 01, 2024 | Sale | $3.84 | 14,029 | 53,913 | 35,362 | Feb 02, 2024, 09:24 PM |
BERGER FRANKLIN M | Director | Nov 14, 2022 | Sale | $5.16 | 16,166 | 83,352 | 778,353 | Nov 15, 2022, 08:00 PM |
BERGER FRANKLIN M | Director | Nov 11, 2022 | Sale | $5.15 | 25,500 | 131,333 | 794,519 | Nov 15, 2022, 08:00 PM |
Murphy Polly A. | Director | Dec 20, 2021 | Buy | $8.57 | 12,000 | 102,796 | 23,295 | Dec 21, 2021, 09:41 PM |
Rock Springs Capital Management LP | 10% Owner | Nov 03, 2020 | Buy | $24.00 | 250,000 | 6,000,000 | 1,654,724 | Nov 04, 2020, 04:05 PM |
Hack Andrew A. F. | Director | Nov 03, 2020 | Buy | $24.00 | 250,000 | 6,000,000 | 5,615,659 | Nov 03, 2020, 09:36 PM |
BERGER FRANKLIN M | Director | Nov 03, 2020 | Buy | $24.00 | 41,666 | 999,984 | 820,019 | Nov 03, 2020, 08:09 PM |
Owner | Relationship | Date | Value($) |
Corcoran Andrea | See Remarks | 02/01/2024 | 60,915 |
Sommadossi Jean-Pierre | President, CEO, and Chairman | 02/01/2024 | 218,819 |
Horga Maria Arantxa | Chief Medical Officer | 02/01/2024 | 60,963 |
Foster Wayne | EVP, Chief Accounting Officer | 02/01/2024 | 47,904 |
Vavricka John | Chief Commercial Officer | 02/01/2024 | 45,420 |
Hammond Janet MJ | Chief Development Officer | 02/01/2024 | 53,913 |
BERGER FRANKLIN M | Director | 11/14/2022 | 83,352 |
BERGER FRANKLIN M | Director | 11/11/2022 | 131,333 |
Murphy Polly A. | Director | 12/20/2021 | 102,796 |
Rock Springs Capital Management LP | 10% Owner | 11/03/2020 | 6,000,000 |
Hack Andrew A. F. | Director | 11/03/2020 | 6,000,000 |
BERGER FRANKLIN M | Director | 11/03/2020 | 999,984 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 9,443,887 | 0.00073% | 15.29% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,807,912 | 0.00058% | 4.76% | Other |
RENAISSANCE TECHNOLOGIES LLC | 1,496,303 | 0.00706% | 10.47% | Other |
TYRUS CAPITAL S.A.M. | 1,260,000 | 35.9% | No change | Event Driven |
D. E. SHAW & CO., INC. | 185,177 | 0.00049% | 164.73% | Other |
ALPS ADVISORS INC | 58,436 | 0.0014% | -5.09% | Other |
AQR CAPITAL MANAGEMENT LLC | 30,353 | 0.00019% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View